| 36.54 Delayed Data As of Oct 19 |  -0.99 / -2.64%Today’s Change | 24.54 Today|||52-Week Range 39.44 | +47.40% Year-to-Date |
| BAX vs. BSX: Which Stock Should Value Investors Buy Now? Oct 19 / Zacks.com - Paid Partner Content | Barclays Takes Action on Health Care Stocks Oct 17 / GuruFocus News - Paid Partner Content |
| Will Boston Scientific's (BSX) Q3 Earnings Reflect Overall Gain? Oct 17 / Zacks.com - Paid Partner Content | Here's Why You Should Invest in Boston Scientific Stock Now Oct 09 / Zacks.com - Paid Partner Content |
| Previous close | 37.53 |
| Today’s open | 37.37 |
| Day’s range | 36.35 - 37.70 |
| Volume | 8,448,540 |
| Average volume (3 months) | 6,913,671 |
| Market cap | $50.5B |
| Earnings growth (last year) | -70.12% |
| Earnings growth (this year) | +10.79% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +7.89% |
| P/E ratio | 96.2 |
| Price/Sales | 3.82 |
| Price/Book | 7.16 |
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | -1.71 | -0.71% |
| ZBHZimmer Biomet Holdin... | -1.92 | -1.52% |
| ABMDAbiomed Inc | -24.21 | -6.26% |
| DXCMDexCom Inc | -3.85 | -2.90% |
| Next reporting date | October 24, 2018 |
| EPS forecast (this quarter) | $0.34 |
| Annual revenue (last year) | $9.0B |
| Annual profit (last year) | $104.0M |
| Net profit margin | 1.15% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Michael F. Mahoney |
Executive Vice President- Operations Edward Mackey |
Corporate headquarters Marlborough, Massachusetts |
